ATE502300T1 - Immunoassay-verfahren - Google Patents

Immunoassay-verfahren

Info

Publication number
ATE502300T1
ATE502300T1 AT03786268T AT03786268T ATE502300T1 AT E502300 T1 ATE502300 T1 AT E502300T1 AT 03786268 T AT03786268 T AT 03786268T AT 03786268 T AT03786268 T AT 03786268T AT E502300 T1 ATE502300 T1 AT E502300T1
Authority
AT
Austria
Prior art keywords
substance
specimen
antibody
target substance
competitive
Prior art date
Application number
AT03786268T
Other languages
English (en)
Inventor
Tatsuya Ohashi
Toshihide Miura
Yoshihiko Igarashi
Fumio Nomura
Takeshi Tomonaga
Katsuhiro Katayama
Original Assignee
Nitto Boseki Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Boseki Co Ltd filed Critical Nitto Boseki Co Ltd
Application granted granted Critical
Publication of ATE502300T1 publication Critical patent/ATE502300T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
AT03786268T 2002-12-26 2003-12-24 Immunoassay-verfahren ATE502300T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002377636 2002-12-26
JP2003123970 2003-04-28
PCT/JP2003/016601 WO2004059320A1 (ja) 2002-12-26 2003-12-24 免疫測定法およびそれに用いるキット

Publications (1)

Publication Number Publication Date
ATE502300T1 true ATE502300T1 (de) 2011-04-15

Family

ID=32684261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03786268T ATE502300T1 (de) 2002-12-26 2003-12-24 Immunoassay-verfahren

Country Status (9)

Country Link
US (1) US7611855B2 (de)
EP (1) EP1582870B1 (de)
JP (1) JP4200503B2 (de)
KR (1) KR100988188B1 (de)
AT (1) ATE502300T1 (de)
AU (1) AU2003296086A1 (de)
DE (1) DE60336427D1 (de)
NO (1) NO338747B1 (de)
WO (1) WO2004059320A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286223A1 (en) * 2006-05-30 2009-11-19 Ewha University-Industry Collaboration Foundation Methods And Kits For In Situ Measurement of Enzyme Activity and Amount Using Single Measurement System
WO2008081922A1 (ja) 2006-12-28 2008-07-10 Nitto Boseki Co., Ltd TRACP5bの製造方法
EP2389585A2 (de) * 2009-01-22 2011-11-30 Li-Cor, Inc. Einzelmolekül-proteomik mit dynamischen sonden
EP2495564B1 (de) 2009-10-28 2015-12-16 Nitto Boseki Co., Ltd Immunoassay-verfahren mit 5,9-kda-peptid
US9157910B2 (en) 2013-03-15 2015-10-13 Abbott Laboratories Assay with increased dynamic range
JP6850254B2 (ja) * 2014-12-18 2021-03-31 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 干渉を減少させるための方法
AU2016301302B2 (en) 2015-08-04 2023-01-12 Vaxiion Therapeutics, Llc Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
JP7313659B2 (ja) * 2019-03-12 2023-07-25 株式会社シノテスト 試料中のｈｍｇｂ１の測定方法及び測定試薬

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769320A (en) * 1982-07-27 1988-09-06 New England Medical Center Hospitals, Inc. Immunoassay means and methods useful in human native prothrombin and human abnormal prothorombin determinations
GB8317124D0 (en) 1983-06-23 1983-07-27 Ekins R P Free ligand assay
DE3624464A1 (de) 1986-07-19 1988-01-28 Boehringer Mannheim Gmbh Verfahren zum nachweis eines analyten sowie hierfuer geeignetes mittel
US5403745A (en) * 1990-04-27 1995-04-04 Genzyme Corporation Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
ATE142344T1 (de) * 1990-11-20 1996-09-15 Behringwerke Ag Immunotest für cyclosporin
IT1254858B (it) * 1992-04-14 1995-10-11 Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.
JPH06289020A (ja) 1993-04-06 1994-10-18 Teijin Ltd 歯槽骨由来タンパクの測定方法
GB9403702D0 (en) * 1994-02-25 1994-04-13 Flow Research Evaluation Diagn Improvements relating to spray generators
JPH10221341A (ja) 1997-02-03 1998-08-21 Mitsui Chem Inc 体液中の遊離リガンドの測定方法
JP3713901B2 (ja) 1997-06-06 2005-11-09 日東紡績株式会社 破骨細胞由来酸性ホスファターゼの測定方法
US6248544B1 (en) 1998-04-01 2001-06-19 Jussi Halleen Method of measuring bone resorption rate
SE9801563D0 (sv) * 1998-04-30 1998-04-30 Pharmacia & Upjohn Diag Ab Förfarande med separation och kit att användas vid förfarandet
WO2001025791A2 (en) 1999-10-07 2001-04-12 Ciphergen Biosystems, Inc. Prostate cancer marker proteins
CA2301451A1 (en) 2000-03-20 2001-09-21 Thang T. Pham Method for analysis of analytes by mass spectrometry
JP2002031640A (ja) 2000-07-17 2002-01-31 Yamasa Shoyu Co Ltd 酒石酸抵抗性酸性ホスファターゼの測定法およびキット
EP1359161B1 (de) 2002-04-30 2010-08-25 Nitto Boseki Co., Ltd. Hybridom fähig zur Produktion eines monoklonalen Antikörpers der spezifisch gegen tartratbeständige Säurephosphatase 5b (TRACP 5b) gerichtet ist.

Also Published As

Publication number Publication date
NO338747B1 (no) 2016-10-17
US7611855B2 (en) 2009-11-03
EP1582870A4 (de) 2008-06-25
EP1582870B1 (de) 2011-03-16
EP1582870A1 (de) 2005-10-05
KR100988188B1 (ko) 2010-10-18
NO20052870D0 (no) 2005-06-13
DE60336427D1 (de) 2011-04-28
KR20050085900A (ko) 2005-08-29
JPWO2004059320A1 (ja) 2006-04-27
WO2004059320A1 (ja) 2004-07-15
JP4200503B2 (ja) 2008-12-24
NO20052870L (no) 2005-09-08
US20060115866A1 (en) 2006-06-01
AU2003296086A1 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
Zhang et al. Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum α-fetoprotein
WO2002090983A3 (de) Quantitaver einschritt immuntest in lyophilisierter form
ATE414106T1 (de) Pegylierte single-domain-antikörper (dab)
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
RU2008135060A (ru) Применение гликозаминогликанов для снижения неспецифического связывания в иммунологических анализах
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
DE60336427D1 (de) Immunoassay-verfahren
ATE374944T1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
ATE447712T1 (de) Immunoassay mit doppelter standardkurve
JP6457933B2 (ja) インスリン測定方法
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
ATE467128T1 (de) Kolloidale metallkonjugate
ATE108907T1 (de) Bestimmungsverfahren, seine verwendung und komponenten.
YU15401A (sh) Antitela visokog afiniteta
FI904304A0 (fi) Foerfarande foer paovisande av analyter.
EP1597579A4 (de) Generisches verfahren für latex-agglutinationstests
DK1399744T3 (da) EPF-receptorassays, forbindelser og terapeutiske præparater
Babaei et al. Development of a New in Vivo Kit for Detection of Prostate Specific Antigen in Human Serum Using Immunoradiometric Assay Method
TH40142A (th) การทดสอบภูมิคุ้มกันสำหรับโปรคอลลาเจน -iii-c- เทอร์มินัล

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties